Rani-Sanorania en es it fr

Rani-Sanorania Brand names, Rani-Sanorania Analogs

Rani-Sanorania Brand Names Mixture

  • Tritec (ranitidine bismuth citrate salt)

Rani-Sanorania Chemical_Formula


Rani-Sanorania RX_link


Rani-Sanorania fda sheet

Rani-Sanorania FDA

Rani-Sanorania msds (material safety sheet)

Rani-Sanorania MSDS

Rani-Sanorania Synthesis Reference

B. J. Price et al., U.S. Pat. 4,128,658 (1978)

Rani-Sanorania Molecular Weight

314.405 g/mol

Rani-Sanorania Melting Point

69-70 oC

Rani-Sanorania H2O Solubility

24.7 mg/mL

Rani-Sanorania State


Rani-Sanorania LogP


Rani-Sanorania Dosage Forms

Capsule; Liquid; Solution; Tablet; Syrup

Rani-Sanorania Indication

Used in the treatment of peptic ulcer disease (PUD), dyspepsia, stress ulcer prophylaxis, and gastroesophageal reflux disease (GERD).

Rani-Sanorania Pharmacology

Ranitidine is a histamine H2-receptor antagonist similar to cimetidine and famotidine. An H2-receptor antagonist, often shortened to H2 antagonist, is a drug used to block the action of histamine on parietal cells in the stomach, decreasing acid production by these cells. These drugs are used in the treatment of dyspepsia, however their use has waned since the advent of the more effective proton pump inhibitors. Like the H1-antihistamines, the H2 antagonists are inverse agonists rather than true receptor antagonists.

Rani-Sanorania Absorption

Approximately 50% bioavailability orally.

Rani-Sanorania side effects and Toxicity

LD50=77mg/kg (orally in mice). Symptoms of overdose include muscular tremors, vomiting, and rapid respiration.

Rani-Sanorania Patient Information


Phenylketonurics: ZANTAC 25 EFFERdose Tablets contain phenylalanine 2.81 mg per 25 mg of ranitidine. ZANTAC 150 EFFERdose Tablets
contain phenylalanine 16.84 mg per 150 mg of ranitidine. ZANTAC EFFERdose Tablets should not be chewed, swallowed whole, or dissolved
on the tongue.

Rani-Sanorania Organisms Affected

Humans and other mammals